Amanote Research
Register
Sign In
OA07.06 Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.273
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
F. Hu
J. Xu
B. Zhang
C. Li
W. Nie
P. Gu
P. Hu
H. Wang
Y. Zhang
Y. Shen
S. Wang
B. Han
X. Zhang
Publisher
Elsevier BV
Related search
Consolidative Local Therapy in Oligometastatic Patients
The Lancet Oncology
Oncology
OA07.05 Local Ablative Therapy Improves Survival in Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated With EGFR-TKIs
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P083 Efficacy of EGFR-TKIs in Patients Harboring EGFR Mutations With Non-Adenocartinoma Histology
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PUB047 Efficacy of EGFR-TKI for Lung Adenosquamous Cell Carcinoma Harboring EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Chemotherapy Combined With Bevacizumab for the Treatment of Advanced Lung Adenocarcinoma Cancer Harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 Mutations: A Case Report
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Post-Progression Survival After EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
PLoS ONE
Multidisciplinary
P3.13-24 Efficacy of EGFR-TKIs Compared With Chemotherapy as First-Line Therapy in Patients With EGFR Rare Mutation Advanced Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA25.06 RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit From Local Consolidative Treatment
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary